Parthak Prodhan
Professor
faculty
Peds Pediatrics, College of Medicine
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Parthak Prodhan, a Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences College of Medicine, focuses his research on outcomes in pediatric cardiac intensive care. His work investigates the utilization of blood products in pediatric patients undergoing extracorporeal membrane oxygenation (ECMO), comparing different anticoagulation strategies. Prodhan has also examined the effects of the COVID-19 pandemic on hospitalizations for life-threatening conditions in children. His scholarship includes seven publications with 41 citations and an h-index of 2. He collaborates with researchers including Erin Bennett and Rachel Slate, both from the University of Arkansas for Medical Sciences, with whom he shares multiple publications.
Research Overview
Pediatric intensivists with specific clinical focus on pediatric cardiac intensive care. Research interests in outcomes research primarily related to mechanical cardiopulmonary support
Metrics
- h-index: 35
- Publications: 152
- Citations: 3,830
Selected Publications
-
517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO (2025)
-
112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin (2024)
-
Sustained Performance of Cardiac Arrest Prevention in Pediatric Cardiac Intensive Care Units (2024)
-
Hospital Outcomes Among Children With Congenital Heart Disease and Adenovirus Pneumonia (2024)
-
Streptococcus pneumoniae associated hemolytic uremic syndrome in children (2023)
-
Extracorporeal Membrane Oxygenation and Hemolytic Uremic Syndrome in Children: Outcome Review of a Multicenter National Database (2023)
-
Evaluation of lung ultrasound to detect volume overload in children undergoing dialysis (2022)
-
Systemic-to-Pulmonary Artery Shunt Thromboprophylaxis: Searching for the Holy Grail* (2022)
-
Norwood Operation: Immediate vs Delayed Sternal Closure (2022)
-
Development of consensus recommendations for the management of post-operative chylothorax in paediatric CHD (2022)
-
Preventing Cardiac Arrest in the Pediatric Cardiac Intensive Care Unit Through Multicenter Collaboration (2022)
-
Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome (2021)
-
Comparison of Postoperative, In-Hospital Outcomes After Complete Repair of Tetralogy of Fallot Between 22q11.2 Deletion Syndrome and Trisomy 21 (2021)
-
Risk Factors for Increased Post-operative Length of Stay in Children with Coarctation of Aorta (2021)
-
Cardiac Manifestation among Children with Hemolytic Uremic Syndrome (2021)
Collaboration Network
Top Collaborators
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 112: Blood Product Utilization after Invasive Procedures in Pediatric ECMO: A Single-Center Retrospective Review Comparing Unfractionated Heparin versus Bivalirudin
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- 517: BLOOD PRODUCT UTILIZATION AFTER INVASIVE PROCEDURES IN PEDIATRIC ECMO
- Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions
- Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions
- Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions
- Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions
- Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions
- Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions
Similar Researchers
Based on overlapping research topics